Teyi Pharmaceutical Group Co., Ltd. (002728)

Overview

Teyi Pharmaceutical Group Co., Ltd. is a prominent entity in the pharmaceutical sector throughout the People's Republic of China, focusing on the discovery, development, manufacturing, and marketing of a wide array of pharmaceutical products. Initially known as Guangdong Taicheng Pharmaceutical Co., Ltd., the enterprise underwent a name change in November 2016 to better reflect its evolved stature and broader objectives in the pharmaceutical industry. Since its establishment in 2002, Teyi Pharmaceutical Group has concentrated its efforts on providing solutions for a variety of health conditions by leveraging traditional Chinese medicine formulations alongside modern pharmaceutical preparations. Headquartered in Taishan City, the company has carved out a significant niche in the Chinese pharmaceutical market, catering to the healthcare needs of a vast population with its diversified product portfolio.

Products and Services

• Cough and Phlegm, Kidney, Anti- Infection, Cardiovascular and Cerebrovascular, Digestive System Drugs

  Teyi Pharmaceutical offers an extensive range of drugs targeting multiple healthcare concerns. These medicines cover a broad spectrum of conditions, including respiratory issues such as cough and phlegm, renal health, infections, cardiovascular and cerebrovascular diseases, and disorders of the digestive system. The company's commitment to a multifaceted approach in medicine enables it to support patients with varied medical needs.

• Pediatrics, Dermatology, Tuberculosis, Respiratory, Rheumatology, Nephrology, and Endocrinology Medicines

  Expanding beyond the common ailments, Teyi Pharmaceutical also presents specialized therapeutic solutions across different medical fields. This includes treatments specific to children's health (pediatrics), skin conditions (dermatology), serious infectious diseases like tuberculosis, disorders related to the respiratory system, bones and joints (rheumatology), kidney function (nephrology), and hormone-related disorders (endocrinology). This diverse portfolio signifies the company's robust research and development capabilities.

• Chemical Raw Materials and Products

  The company's chemical division manufactures and distributes a wide array of essential chemical raw materials and products which are pivotal to the pharmaceutical industry. This range encompasses aluminum carbonate, phenytoin, ferrous sulfate, glacial acetic acid, calcium chloride, sodium chloride, alongside a variety of products in the bismuth and citric acid series, and zinc sulfate. These materials play crucial roles in the manufacturing of numerous pharmaceutical formulations, highlighting Teyi Pharmaceutical's integral position within the supply chain of the broader pharmaceutical manufacturing sector.